PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Prospective Validation of the ROL System in Substaging Pt1 High-Grade Bladder Cancer: Results from a Prospective Mono-Institutional Confirmatory Analysis in BCG Treated Patients
Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers2023, 15, 934.
Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers 2023, 15, 934.
Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers2023, 15, 934.
Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers 2023, 15, 934.
Abstract
Patients with pT1 high-grade (HG) bladder cancer (BC) and a very high risk of progression might benefit from immediate radical cystectomy (RC), but this option remains controversial. Validation of a standardized method to evaluate the extent of lamina propria (LP) invasion (with recognized prognostic value) in transurethral resections (TURBT) specimens is still needed. The Rete Oncologica Lombarda (ROL) system showed a high predictive value for progression after TURBT in recent retrospective studies. Our aim was to validate ROL system on a large mono-institutional prospective series of primary urothelial carcinomas. From 2016 to 2020, we adopted ROL for all patients with pT1 HG BC on TURBT. We employed a 1.0-mm threshold to stratify tumors in ROL1 and ROL2. A total of 222 pT1HGBC were analyzed. Median age was 74 years, with male predominance (73.8%). ROL was feasible in all cases: 91 cases were ROL1 (41%) and 131 ROL2 (59%). At a median follow up of 26.9 months (IQR 13.8-40.6), we registered 80 recurrences and 40 progressions. ROL was a significant predictor of tumor progression at both univariable (HR 3.53; CI 95% 1.56 – 7.99; p<0.01) and multivariable (HR 2.90; CI 95% 1.25 – 6.75; p=0.01) Cox regression analyses. At Kaplan-Meier estimates, ROL showed correlation with both PFS (p=0.0012) and RFS (p=0.0167). Our results confirmed the strong predictive value of ROL for progression on a large prospective series. We encourage the application of ROL for reporting the extent of LP invasion, substaging T1 HG BC, and improving risk tables for urological decision making.
Medicine and Pharmacology, Pathology and Pathobiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.